MYC Amplification in Metastatic Prostate Cancer Associated with Reduced Tumor Immunogenicity
March 11, 2026
A new research paper was published in Volume 13 of Oncoscience on February 7, 2026, titled “Reduced immunogenicity of MYC amplified, metastatic prostate cancer.” continue reading »